Zolmitriptan and Stroke - a phase IV clinical study of FDA data

Summary:

Stroke is reported as a side effect among people who take Zolmitriptan (zolmitriptan), especially for people who are female, 60+ old, have been taking the drug for 1 - 6 months also take Risedronate Sodium, and have Osteoarthritis.

The phase IV clinical study analyzes which people have Stroke when taking Zolmitriptan. It is created by eHealthMe based on reports of 2,530 people who have side effects when taking Zolmitriptan from the FDA, and is updated regularly.

What is Zolmitriptan?

Zolmitriptan has active ingredients of zolmitriptan. It is often used in migraine. eHealthMe is studying from 2,568 Zolmitriptan users. Check the latest studies of Zolmitriptan.

What is Stroke?

Stroke (sudden death of a portion of the brain cells due to a lack of oxygen) is found to be associated with 2,365 drugs and 3,014 conditions by eHealthMe. Check the latest studies of Stroke.

On Jan, 22, 2026

2,530 people reported to have side effects when taking Zolmitriptan.
Among them, 49 people (1.94%) have Stroke.

Among these 49 people:

How long have people been on Zolmitriptan when they have Stroke? *

What is the gender of people who have Stroke when taking Zolmitriptan? *

female: 90.91 %
male: 9.09 %

What is the age of people who have Stroke when taking Zolmitriptan? *

What are other drugs people take besides Zolmitriptan? *

What are other side effects people have besides Stroke? *

Cough: 29 people, 59.18%
Dyspnea (difficult or laboured breathing): 29 people, 59.18%
High Blood Pressure: 7 people, 14.29%
Headache (pain in head): 6 people, 12.24%
Fatigue (feeling of tiredness): 6 people, 12.24%
Weight Decreased: 6 people, 12.24%
Vision Blurred: 6 people, 12.24%
Heart Rate Decreased: 5 people, 10.20%
The Flu (the flu is caused by an influenza virus): 5 people, 10.20%
Infusion Related Reaction: 5 people, 10.20%

What are the existing conditions these people have? *

Osteoarthritis (a joint disease caused by cartilage loss in a joint): 29 people, 59.18%
Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 28 people, 57.14%
Asthma: 27 people, 55.10%
Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 27 people, 55.10%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 23 people, 46.94%
Ill-Defined Disorder: 13 people, 26.53%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 5 people, 10.20%
Headache (pain in head): 2 people, 4.08%
Cardiac Disorder: 2 people, 4.08%
Depression: 2 people, 4.08%

* Approximation only. Some reports may have incomplete information.

Do you take Zolmitriptan and have Stroke?

- Check whether Stroke is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Zolmitriptan:

Zolmitriptan (2,568 reports)

Stroke treatments and more:

Stroke (334,632 reports)

Browse all side effects of Zolmitriptan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Stroke:

Stroke (2,365 drugs)

Browse all the conditions that are associated with Stroke:

Stroke (3,014 conditions)

Drugs similar to Zolmitriptan and Stroke :

How the study uses the data?

The study uses data from the FDA. It is based on zolmitriptan (the active ingredients of Zolmitriptan) and Zolmitriptan (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.